DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
Active substance: DAPAGLIFLOZIN, METFORMIN HYDROCHLORIDE
TABLET, EXTENDED RELEASE · DAPAGLIFLOZIN 5 mg/1, METFORMIN HYDROCHLORIDE 1000 mg/1
United StatesActive
Marketing holder: Lupin Pharmaceuticals, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- DAPAGLIFLOZIN · 5 mg/1
- METFORMIN HYDROCHLORIDE · 1000 mg/1
Products containing dapagliflozin in other countries
Showing products with this active substance, combinations included; the full composition is shown for each product.
| Country | Products |
|---|---|
| EU 2 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-278d-7918-a60e-ce38f5d3cb2f,01a1208d-1711-7bd1-a763-4fbee36f6760,01a1208d-2eb2-7706-84c6-467b0cec14aa,01a1208d-2eb5-78f7-861a-881d74b321ec,01a1208d-83c7-7983-ba67-9e7cbb55b234;count=38 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 70748-102
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 70748-102 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 70748-102 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 70748-102 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 70748-102 · Verified 2026-10-09 · open in source